Objectives

• Monitor Environmental Changes
• Advocacy
• Managing uncertainty
• Pricing studies
• Market Access focus on specific products

Activities

• Pricing
  • P&R environment
  • Price sensitivity
  • Payer research
  • External reference pricing
  • Pricing sequence
  • Price strategy
  • P&R risk evaluation
• Building an effective advocacy strategy to support market access
• Market access specificities in emerging countries
• Market access of specific products
  • Orphan drugs
  • Oncology products
  • Regenerative medicine (one full day) New
  • Mature products
  • Value added medicine
  • Combined products (fix combination and device drugs combination)
  • Biosimilars

Workshop & Case study